Lymphoid Malignant Tumours - Discovered Of A New Therapeutic Strategy
The preclinic studies in a mould in vivo pageantry that the activation of the calcineurine is crucial for the preservation of the tumoral motion distinct lymphomas and LAL. The cyclosporine and the FK506 causation the decease of the tumoral cells indeed. A clinical probation should quickly bring about at the School Curie to evaluate the inherent of this contemporary therapeutic strategy, and in specific of the FK506, for the treatment of the lymphomas.The lymphomas are tumours of the peripheral lymphoid action which ensures the defence of the construction against the pathogenic agents. They generally maturate in the lymphatic ganglia.
One classifies them in two leading categories according to the implied cells and the energy of evolution of the tumour. One thus distinguishes the lymphomas not hodgkiniens which touch almost 9.000 commonality in France and belong to cancers of which the closeness increased the most these at the end years, and the lymphomas of Hodgkin, rarer with 1.300 cases and whose incidence does not evolve/move. Provided the disease of Hodgkin touches exclusively adolescent adults, the other lymphomas relate to older subjects.
The lymphomas generally mature starting from the lymphocytes B (1) and in some rarer cases of the lymphocytes T. They are characterized by the malignant proliferation of lymphoid cells which tend to infiltrate all the organization. The lymphocytes accumulate since of their incapacity with autodetruire by apoptose (2), invade the ganglia, spleen then gradually osseous core and blood. As osseous spirit is the seat of the hematopoïese (3) adult, this invasion involves a modularly insufficiency. This phenomenon then causes an more and more flimsy industry of bittersweet globules which causes an anaemia, a fall of the immunity involving of the cold sober infections and a diminution of the plates, at the origin of haemorrhages. The most universal shapes of cancers in the children until adolescence, besides existence able to materialize in the adults, acute leukaemias lymphoid T (LAL-T) are characterized, as for them, by an uncontrolled proliferation of immature cells T which invade osseous marrow, blood and the central apprehensive process with the detriment of the average cells.
The calcineurine "to repair" the lymphocytesThe aggregation "Oncogènes and hematopoietic differentiation" of the UMR 146 CNRS/Institute Curie, directed by Jacques Ghysdael scan the heterogeneous forms of leukaemia and the cellular mechanisms meaningful to their development. It has fair-minded shown that the calcineurine is activated in a durable groove in the lymphocytes B and T tumoral of the diverse lymphomas and lymphoid acute leukaemias.
This protein phosphates plays an valuable department in the ordinary course of the lymphocytes B and T and again takes atom in the activation of these cells during the immunizing answer. The calcineurine, once activated, starts the proliferation of the lymphocytes T via the production of a lymphocytary expansion promoter, the interleukine 2. However, the bustle of the calcineurine is inhibited by the cyclosporine and FK506, two immunosuppresseurs used in private clinic to prevent the rejection of Clerc's Support of bodies.
While using models in vivo carrying lymphomas or LAL, researchers CNRS of Institut Curie come to appearance that the inhibition of the calcineurine by cyclosporine A or the FK506 results in departure by apoptose lymphoid cells and a tumoral regression. The calcineurine is thus needed with the maintenence of the tumoral characteristics of the lymphocytes T or B in the lymphomas and LAL, which makes a recent therapeutic oppose of it. These two molecules life already used in private clinic, of the tests therapeutic should quickly start, aboriginal of all with the FK506, in codification to evaluate their likely on lymphomas not hodgkiniens and lymphomas hodgkiniens. Intermediate results of tolerance and effectiveness are awaited as of the succeeding year.